Cargando...
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
Bronchodilators, including long-acting β(2)-agonists and long-acting muscarinic antagonists, are the mainstay for treatment of patients with chronic obstructive pulmonary disease (COPD) to prevent exacerbations or reduce symptoms. Formoterol is a highly selective and potent β(2)-agonist that relaxes...
Gardado en:
| Publicado en: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708267/ https://ncbi.nlm.nih.gov/pubmed/33273813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S273497 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|